These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Vermont Oxford Network Steroid Study Group Pediatrics; 2001 Sep; 108(3):741-8. PubMed ID: 11533345 [TBL] [Abstract][Full Text] [Related]
3. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Halliday HL; Ehrenkranz RA Cochrane Database Syst Rev; 2001; (2):CD001145. PubMed ID: 11405975 [TBL] [Abstract][Full Text] [Related]
4. Effect of dexamethasone on blood pressure--relationship to postnatal age. Emery EF; Greenough A Eur J Pediatr; 1992 May; 151(5):364-6. PubMed ID: 1396892 [TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Israel BA; Sherman FS; Guthrie RD Am J Perinatol; 1993 Jul; 10(4):307-10. PubMed ID: 8397569 [TBL] [Abstract][Full Text] [Related]
6. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday H; Shah VS Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423 [TBL] [Abstract][Full Text] [Related]
7. Cardiac effects of short course dexamethasone in preterm infants. Skelton R; Gill AB; Parsons JM Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F133-7. PubMed ID: 9577285 [TBL] [Abstract][Full Text] [Related]
8. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Halliday HL; Ehrenkranz RA Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251 [TBL] [Abstract][Full Text] [Related]
9. Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants. Romagnoli C; Zecca E; Vento G; De Carolis MP; Papacci P; Tortorolo G Intensive Care Med; 1999 Jul; 25(7):717-21. PubMed ID: 10470576 [TBL] [Abstract][Full Text] [Related]
11. The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease. Shrivastava A; Lyon A; McIntosh N Eur J Pediatr; 2000 May; 159(5):380-4. PubMed ID: 10834526 [TBL] [Abstract][Full Text] [Related]
12. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray. Schrod L; Neuhaus T; Horwitz AE; Speer CP Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920 [TBL] [Abstract][Full Text] [Related]
13. Corticosteroids and chronic lung disease in extremely immature infants: a dilemma. Moriette G; Mikaeloff Y; Jarreau PH; Desfrère L Pediatr Pulmonol Suppl; 1999; 18():209-11. PubMed ID: 10093145 [TBL] [Abstract][Full Text] [Related]
14. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Brion LP; Primhak RA; Ambrosio-Perez I Cochrane Database Syst Rev; 2000; (3):CD001817. PubMed ID: 10908511 [TBL] [Abstract][Full Text] [Related]
15. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Brion LP; Primhak RA; Ambrosio-Perez I Cochrane Database Syst Rev; 2000; (2):CD001817. PubMed ID: 10796274 [TBL] [Abstract][Full Text] [Related]
16. Corticosteroids in infant chronic lung disease. May C; Greenough A Monaldi Arch Chest Dis; 2004; 61(3):162-6. PubMed ID: 15679010 [TBL] [Abstract][Full Text] [Related]
17. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial. Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659 [TBL] [Abstract][Full Text] [Related]